Author

George Betts

Institution: Regeneron (United States)

Observed institutions: Regeneron (United States), Ipsen (United States)

OpenAlex ID: A5062453695

Compassionate Use of REGEN-COV® in Patients With Coronavirus Disease 2019 (COVID-19) and Immunodeficiency-Associated Antibody Disorders

2021 · David Stein, Ernesto Oviedo-Orta, et al. · Clinical Infectious Diseases · 12

ANCHOR-CD ( A bobotulinumtoxinA N eurotoxin: C linical and H ealth Economics O utcomes R egistry in C ervical D ystonia): A Multicenter, Observational Study of Dysport in Cervical Dystonia: Baseline Data and Cycle One Efficacy Data (P07.191)

2013 · Richard Trosch, Patricia Jozefczyk, et al. · Neurology

Works count: 2

Citation count: 12

H-index: 1

I10-index: 1